Lisa Mosconi

Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL.

Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL.

Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL.

Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL.

Abiant, Inc. provides advanced imaging technology services. The firm designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. Its image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. The company was founded in 2005 and is headquartered in Grayslake, IL.